Statistics
Publications
4
Citations
191
H-Index
4
Active since
2016
Mika Sunakawa is an author at Nippon Medical School specializing in oncology, multiple myeloma therapy, and drug-induced apoptosis.
Publications per year
2016–2024
4
4
Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1
Mariko Ishibashi, Hideto Tamura, Mika Sunakawa et al. · Cancer Immunology Research · 2016 · 95 citations
Medicine, Oncology, Pharmacology +17
Clinical impact of serum soluble SLAMF7 in multiple myeloma
Mariko Ishibashi, Saori Soeda, Makoto Sasaki et al. · Oncotarget · 2018 · 54 citations · Full text
Medicine, Immunology, Oncology +15
1–4 of 4